Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Accounts Payables (2016 - 2025)

Ingevity (NGVT) has disclosed Accounts Payables for 11 consecutive years, with $92.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 2.65% to $92.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $92.0 million, a 2.65% decrease, with the full-year FY2025 number at $92.0 million, down 2.65% from a year prior.
  • Accounts Payables was $92.0 million for Q4 2025 at Ingevity, down from $100.9 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $203.6 million in Q2 2023 to a low of $92.0 million in Q4 2025.
  • A 5-year average of $137.1 million and a median of $128.2 million in 2021 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: skyrocketed 50.24% in 2021, then tumbled 51.09% in 2024.
  • Ingevity's Accounts Payables stood at $125.8 million in 2021, then skyrocketed by 38.95% to $174.8 million in 2022, then decreased by 9.38% to $158.4 million in 2023, then crashed by 40.34% to $94.5 million in 2024, then fell by 2.65% to $92.0 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Accounts Payables are $92.0 million (Q4 2025), $100.9 million (Q3 2025), and $101.5 million (Q2 2025).